Biogen
Innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases.
Launch date
Employees
Market cap
AUD44.5b
Enterprise valuation
AUD51.9b (Public information from Sep 2024)
Share price
$201.44 BIIB
Cambridge Massachusetts (HQ)
Corporate Venture Fund: Biogen Idec New Ventures
Authorizing premium user...